Home page > Europe and Health | Health, wealth and equity | Health friendly research and innovation | EU Funding and programmes | Irish Presidency priorities

Research


Please find all related articles below.



Support the European Data in Health Research Alliance!


A new European Data in Health Research Alliance was launched in early December. This campaign, supported by a number of health organisations active across Europe and representing research, patient and public health concerns, was set up to demonstrate in the most tangible way that personal data in research is vital because it saves lives. The Alliance was established by Cancer Research UK, the Medical Sciences Committee of Science Europe, European Patients’ Forum, the Federation of (...)
18/12/2014

[EASL Press Release] Liver disease in Europe: new study reveals pressing need to focus on research and policy action


Brussels, 10 December 2014 – Today, in an event hosted by MEP Cristian Buşoi (EPP, RO) in the European Parliament, the European Association for the Study of the Liver (EASL) (1) launched the ‘Research Roadmap for Liver Disease (HEPAMAP) - Case study for chronic diseases & research’ (2). The HEPAMAP stresses the need for further research on liver disease and calls on policy makers to step up their efforts to tackle the disease and its links with lifestyle and other (...)
10/12/2014

Carlos Moedas » European Commissioner for Research, Science and Innovation


Carlos Moedas (age 44) studied engineering at Lisbon University, Portugal and an MBA at Harvard University, USA. He worked for Goldman Sachs and EuroHypo investment bank before returning to Portugal in 2004 to join a property consulting company, and established his own property investment company in 2008. He led negotiations for the Social Democratic Party (PSD) for Portugal’s 2011 State Budget. He was elected as an MP in the same year, and leading implementation of the (...)
05/11/2014

5th ESWI Influenza Conference highlights benefits of vaccination


The fifth international influenza conference organised by EPHA member the European Scientific Working Group on Influenza (ESWI) took place in Riga on 14-17 September. A number of plenary and ’science/policy interface’ sessions examined the issue of low vaccination uptake in many Member States, as well as other issues related to pandemic preparedness and communication aspects of influenza-related health threats. In the opening plenary, ’Why should influenza be a public (...)
26/09/2014

[EPHA Report] The sixty-seventh World Health Assembly (WHA)


From 19 to 24 May 2014, the Sixty-seventh session of the World Health Assembly (WHA) took place in Geneva. The WHA is the supreme decision-making body of World Health Organization (WHO). It determines the policies of the WHO, appoints its Director-General, supervises the organisation’s financial policies, and reviews and approves the proposed programme budget. The WHA is attended by delegations from all WHO Member States and focuses on a specific health agenda prepared by the (...)
06/06/2014

[EPHA statement] On-going review of European Food Safety Authority 2012 implementing rules of the Declaration of Interests Policy


On 15 December 2011, the European Food Safety Authority (EFSA) Management Board adopted its Authority’s Policy on independence and scientific decision-making processes. A few months later EFSA’s Executive Director signed off a set of implementing rules on Declarations of Interests (DoIs). These rules regulate the way EFSA should process DoIs and prevent the occurrence of conflicts of interests. Background The current system of declarations of interests and their subsequent (...)
05/06/2014

Every day should be patients’ rights day


Active Citizenship Network (ACN) decided to dedicate the 8th celebration of European Patients’ Rights Day in 2014 to "the role of citizens’ organisations in the empowerment of patients with chronic diseases." On 12 May, speakers examined the different chronic disease networks (e.g. cancer, diabetes, chronic obstructive pulmonary disease(COPD)) and their impacts on political decision making. On 13 May, EPHA participated in the panel discussion on how research policy can respond (...)
13/05/2014

European Gender Medicine Project kicks off in Brussels


In a one day, launch conference, the European Gender Medicine Project (EUGenMed) partners met with ninety experts and key stakeholders to assess the role of gender medicine (GM) in Europe. The launch conference marked the first of a series of project meetings under the DG Research and Innovation-funded Framework Seven Programme (FP7) project to be held in 2014 and 2015 that will culminate in the development of a roadmap for the further implementation of sex and gender (S&G) in (...)
22/04/2014

[Press Release] European Parliament takes leap towards patient safety


Brussels, 3 April 2014 – EPHA welcomes the majority of the measures adopted yesterday by the European Parliament as part of the revision of the EU Medical Devices Directive (MDD) and the In Vitro Diagnostic Medical Devices (IVD) Directive. After a year and a half of proposals (1) and in-depth discussions, it is time to rebuild the trust of patients around Europe. “As the protection of patient safety is a paramount objective, the European Parliament has today taken a (...)
03/04/2014

Post-2015: The role of Global Health Research and Development (R&D) in the new development framework


This position paper, supported by 23 leading Global Health NGOs from both sides of the Atlantic, calls on both public and private stakeholders to ensure that R&D investment targets for poverty-related and neglected diseases (PRNDs) are guaranteed and strongly supported across the board. Research and innovation are critical components in the right to health for all While everybody recognises that health is an essential precondition for development, the research and innovation (...)
24/02/2014